Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French …
Objectives To describe (i) the trend in oral anticoagulant (OAC) use following the
introduction of non-vitamin K antagonist oral anticoagulant (NOAC) therapy for stroke …
introduction of non-vitamin K antagonist oral anticoagulant (NOAC) therapy for stroke …
Prescription patterns and outcomes of patients with atrial fibrillation treated with direct oral anticoagulants and warfarin: a real-world analysis
Background: Direct oral anticoagulants (DOACs) have been found to be similar or superior
to warfarin in reducing ischemic stroke and intracranial hemorrhage (ICH) in patients with …
to warfarin in reducing ischemic stroke and intracranial hemorrhage (ICH) in patients with …
Variation in the use of warfarin and direct oral anticoagulants in atrial fibrillation and associated cost implications
Background Little is known about national patterns of anticoagulant use among patients with
atrial fibrillation after the availability of direct oral anticoagulants (DOACs) and the …
atrial fibrillation after the availability of direct oral anticoagulants (DOACs) and the …
Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effective
J Maervoet, N Bossers, RP Borge Jr… - Journal of Medical …, 2019 - Taylor & Francis
Objectives: Atrial fibrillation (AF) is the most common arrhythmia and a major marker of
ischemic stroke risk. Early detection is crucial and, once diagnosed, anticoagulation therapy …
ischemic stroke risk. Early detection is crucial and, once diagnosed, anticoagulation therapy …
Coagulation studies: achieving the right mix in a large laboratory network
R Blennerhassett, E Favaloro, L Pasalic - Pathology, 2019 - Elsevier
Basic coagulation tests, activated partial thromboplastin time (APTT), prothrombin time (PT)
and the related international normalised ratio (INR), are performed frequently in hospital …
and the related international normalised ratio (INR), are performed frequently in hospital …
Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation—a qualitative study
E Aarnio, R Huupponen… - Basic & Clinical …, 2019 - Wiley Online Library
Direct oral anticoagulants provide an alternative to vitamin K antagonists for the
anticoagulation therapy in atrial fibrillation (AF). The availability of several treatment options …
anticoagulation therapy in atrial fibrillation (AF). The availability of several treatment options …
Identifying clinical predictors of switching from direct oral anticoagulants to warfarin
A Rollins, S Hanigan, K Pogue… - Clinical Medicine …, 2019 - journals.sagepub.com
Purpose: Direct oral anticoagulants (DOACs) have been shown to be as effective or superior
to warfarin, but warfarin use remains constant. Knowledge regarding the patient population …
to warfarin, but warfarin use remains constant. Knowledge regarding the patient population …
[PDF][PDF] Betydande faktorer vid val av antikoagulationsbehandling för patienter med förmaksflimmer: En kvalitativ intervjustudie med hälso-och sjukvårdspersonal om …
N Sebaa - 2019 - diva-portal.org
Inledning: Under år 2016 drabbades 26 500 personer av stroke i Sverige, en blodpropp i
hjärnan som kan ge upphov till en rad komplikationer. En vanlig riskfaktor för att drabbas av …
hjärnan som kan ge upphov till en rad komplikationer. En vanlig riskfaktor för att drabbas av …
[PDF][PDF] Vilka faktorer påverkar valet av orala antikoagulantia som strokeprofylax vid förmaksflimmer?: En enkätstudie bland hälsopersonal i Sverige
E Curic - 2019 - diva-portal.org
Introduktion: NOAK är orala antikoagulantia som används som strokeprofylax vid
förmaksflimmer. Det har gått 10 år sedan NOAK publicerades på marknaden i Sverige …
förmaksflimmer. Det har gått 10 år sedan NOAK publicerades på marknaden i Sverige …